Insider Trading & Ownership - Albright Charles

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Albright Charles
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-12-15
Sale
2020-12-17
6:58 pm
Editas Medicine Inc. EDIT Albright Charles
EVP/Chief Scientific Officer
10,000 $63.22 $632,156 169,907
(Direct)
View
2020-12-09
Sale
2020-12-11
4:14 pm
Editas Medicine Inc. EDIT Albright Charles
EVP/Chief Scientific Officer
10,000 $45 $450,000 179,907
(Direct)
View
2020-12-07
Sale
2020-12-08
4:12 pm
Editas Medicine Inc. EDIT Albright Charles
EVP/Chief Scientific Officer
20,000 $40.02 $800,400 189,907
(Direct)
View
2020-11-09
Sale
2020-11-10
4:13 pm
Editas Medicine Inc. EDIT Albright Charles
EVP/Chief Scientific Officer
228 $31.21 $7,116 24,907
(Direct)
View
2020-10-15
Sale
2020-10-16
4:38 pm
Editas Medicine Inc. EDIT Albright Charles
EVP/Chief Scientific Officer
3,000 $31.39 $94,170 25,135
(Direct)
View
2020-08-17
Sale
2020-08-19
4:44 pm
Editas Medicine Inc. EDIT Albright Charles
EVP/Chief Scientific Officer
10,000 $35.29 $352,900 213,135
(Direct)
View
2020-08-06
Sale
2020-08-10
4:24 pm
Editas Medicine Inc. EDIT Albright Charles
EVP/Chief Scientific Officer
10,238 $37.41 $383,028 223,135
(Direct)
View
2020-07-15
Sale
2020-07-17
5:32 pm
Editas Medicine Inc. EDIT Albright Charles
EVP/Chief Scientific Officer
3,000 $32.22 $96,660 28,373
(Direct)
View
2020-05-06
Sale
2020-05-08
4:17 pm
Editas Medicine Inc. EDIT Albright Charles
EVP/Chief Scientific Officer
151 $25.28 $3,817 31,373
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2020-12-15
Exercise
2020-12-17
6:58 pm
N/A
2026-09-08
Editas Medicine Inc. EDIT Albright Charles
EVP/Chief Scientific Officer
10,000 $0 169,907
(Direct)
View
2020-12-15
Exercise
2020-12-17
6:58 pm
N/A
N/A
Editas Medicine Inc. EDIT Albright Charles
EVP/Chief Scientific Officer
10,000 $16.51 169,907
(Direct)
View
2020-12-09
Exercise
2020-12-11
4:14 pm
N/A
2026-09-08
Editas Medicine Inc. EDIT Albright Charles
EVP/Chief Scientific Officer
10,000 $0 179,907
(Direct)
View
2020-12-09
Exercise
2020-12-11
4:14 pm
N/A
N/A
Editas Medicine Inc. EDIT Albright Charles
EVP/Chief Scientific Officer
10,000 $16.51 179,907
(Direct)
View
2020-12-07
Exercise
2020-12-08
4:12 pm
N/A
2026-09-08
Editas Medicine Inc. EDIT Albright Charles
EVP/Chief Scientific Officer
20,000 $0 189,907
(Direct)
View
2020-12-07
Exercise
2020-12-08
4:12 pm
N/A
N/A
Editas Medicine Inc. EDIT Albright Charles
EVP/Chief Scientific Officer
20,000 $16.51 189,907
(Direct)
View
2020-08-17
Exercise
2020-08-19
4:44 pm
N/A
2026-09-08
Editas Medicine Inc. EDIT Albright Charles
EVP/Chief Scientific Officer
10,000 $0 213,135
(Direct)
View
2020-08-17
Exercise
2020-08-19
4:44 pm
N/A
N/A
Editas Medicine Inc. EDIT Albright Charles
EVP/Chief Scientific Officer
10,000 $16.51 213,135
(Direct)
View
2020-08-06
Exercise
2020-08-10
4:24 pm
N/A
2026-09-08
Editas Medicine Inc. EDIT Albright Charles
EVP/Chief Scientific Officer
10,000 $0 223,135
(Direct)
View
2020-08-06
Exercise
2020-08-10
4:24 pm
N/A
N/A
Editas Medicine Inc. EDIT Albright Charles
EVP/Chief Scientific Officer
10,000 $16.51 223,135
(Direct)
View